Latest Breaking News & Top Headlines

Covid US: Experts advise White House to LEAVE plan to give everyone booster shots


Experts are urging the White House to drop its plan to roll out COVID-19 vaccine boosters to all Americans, according to a new report.

A group of non-government vaccine experts — some of whom even joined President Biden’s transition team — advised federal officials to limit the scope of the booster’s rollout, sources familiar with the matter told POLITCO.

The intention to make additional shots of the vaccine available has been controversial among health experts since it was first revealed in August.

Many doctors have spoken out against making third shots available to all Americans, and the shots failed to receive regulatory approval by the targeted September 20 launch date.

Outside advisors reportedly told federal officials on Sept. 27 to scrap plans to roll out COVID-19 vaccine boosters to all Americans. The booster rollout has seen many setbacks since its announcement at the end of August. Pictured: A woman in Miami, Florida, gets a Covid booster shot on Oct

dr.  Anthony Fauci (pictured) was in talks with the outside advisors and opposed their recommendations

dr. Anthony Fauci (pictured) was in talks with the outside advisors and opposed their recommendations

POLITICO reports that the conversation took place on September 27, and included Dr. Anthony Fauci, the nation’s top infectious disease expert, and Cameron Webb, a White House policy adviser, and other leaders of the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC).

It was reportedly a tense conversation, with Fauci and other federal officials flinching from the advice of the outsiders.

“It was mostly like Fauci felt he should make a point,” a source familiar with the call told Politico.

The Biden administration first announced plans to make booster shots available to every American by the end of August.

Shots would become available to anyone who received the Pfizer-BioNTech or Moderna vaccine six months after receiving their second injections.

However, the plan awaited regulatory approval and immediately faced criticism from health experts and some regulators.

A group of 18 senior FDA officials wrote a report against the booster shots, saying doses should instead be donated to other countries to prevent the emergence of variants abroad.

Among them were Dr. Philip Krause and Dr. Marion Gruber, two officials who plan to resign soon in protest at the White House’s decision to announce the booster shots before regulators had a chance to evaluate the data.

Krause will leave in early November, while Gruber will retire at the end of the month.

President Joe Biden (pictured) urged to have boosters available by Sept. 20 for all Americans who received the Pfizer or Moderna vaccine, although the additional shots were not approved by regulators

President Joe Biden (pictured) urged to have boosters available by Sept. 20 for all Americans who received the Pfizer or Moderna vaccine, although the additional shots were not approved by regulators

In late September, the FDA gave emergency use approval for the Pfizer booster injection, but only to Americans over age 65 or those at high risk due to subordinate circumstances or their job.

Some advisors to the FDA and CDC both oppose the universal rollout of boosters because of limited evidence that the shots are needed at this time.

The Moderna vaccine booster is still awaiting approval, although data from the company has been submitted to regulators.

The one-time Johnson & Johnson vaccine is also likely to get a booster shot in the near future, with the company filing its application with the FDA only this week.

The White House wanted to roll out boosters to counteract the declining efficacy of the available Covid vaccines.

Studies have shown that the vaccine’s effectiveness in preventing infections can drop below 50 percent months after administration.

Although the risk of infections is increasing, breakthrough cases still rarely lead to hospitalization or death.

Because of the vaccine’s ability to prevent severe cases of the virus, FDA officials still find the two-shot regimen effective.

While the idea of ​​further reducing the number of COVID-19 cases by improving immunity in vaccinated people is appealing, any decision to do so must be evidence-based and consider the benefits and risks to individuals and society. ‘, the officials wrote in the report.

‘COVID-19 vaccines remain effective against serious diseases, including those caused by the Delta variant.

“However, most of the observational studies on which this conclusion is based are preliminary and difficult to interpret precisely because of possible confounding and selective reporting.”

dr. Anna Durbin, an international health professor at Johns Hopkins University in Baltimore, Maryland, told that the goals of counselors who support booster shots for all Americans are “unrealistic.”

“The advisors who are pro-booster expect sterilizing immunity – they want the vaccines to prevent infection. This is unrealistic as COVID is a respiratory virus and is not necessary,” she wrote in an email.

“…Transmission from vaccinated people is not the driving force behind the spread of COVID, it is transmission from unvaccinated people.

‘Getting everyone in the world vaccinated must be a priority.’

Currently, only about 46 percent of the world’s population has received at least one shot of a Covid vaccine.

The rollout is especially dire in Africa, where less than seven percent of the continent’s population has been stabbed.

While a majority of Americans are fully vaccinated, variants can crop up elsewhere in the world and eventually arrive in the United States — such as the Delta variant that originated in India.

Experts fear that a vaccine-resistant variant could eventually emerge, putting the world in the same situation from the start of the pandemic.


Leave A Reply

Your email address will not be published.